
Psychedelic Therapies Reach Turning Point Amid Federal Push, Says Scott Shannon, MD
May 12, 2026 - 00:16:32
Radio and PodcastLive Radio & Podcasts
Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer with the International Myeloma Foundation and professor in the Applied Cancer Research and Drug Discovery Division of the Translational Genomics Research...
Frailty, Innovation, and the Future of Myeloma Treatment With Joseph Mikhael, MD is an episode from Managed Care Cast by Managed Care Cast. Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer with the International Myeloma Fo...
This episode belongs to Managed Care Cast.
Use the player on this page to stream the episode online.
Published Mar 31, 2026, 00:28:06 long, audio available.
Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer with the International Myeloma Foundation and professor in the Applied Cancer Research and Drug Discovery Division of the Translational Genomics Research Institute, has spent more than 25 years advancing the treatment of multiple myeloma. In this episode, he breaks down how improved survival, evolving frailty assessments, and the rise of therapies like CAR T and bispecific antibodies are reshaping care for an aging population, and he highlights the growing emphasis on quality of life, caregiver support, and expanding clinical trial access.
You can listen to Frailty, Innovation, and the Future of Myeloma Treatment With Joseph Mikhael, MD online on Radio and Podcast. Open the player on this page to stream the available audio.
Frailty, Innovation, and the Future of Myeloma Treatment With Joseph Mikhael, MD is an episode from Managed Care Cast by Managed Care Cast.
This episode is 00:28:06 long.
This episode was published on Mar 31, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Managed Care Cast when more episodes are available from the podcast feed.